USCAP Annual Meeting Long Course Keeping it Real Merging Traditional and Contemporary Practices in Musculoskeletal Pathology 2025

Target Audience

Learning Objectives

• Review the essential diagnostic criteria for common diseases of the bones and joints, both neoplastic and non-neoplastic.
• Provide a practical overview of updated diagnostic criteria of existing neoplasms and newly described entities that have emerged since 2013, emphasizing those that are more likely to impact patient management.
• Discuss important advances in ancillary testing techniques that are anticipated to improve our prognostic and diagnostic capabilities for bone and soft tissue tumors.

+ Topics:

• Updates in Peripheral Nerve Sheath and Adipocytic Tumors – Sarah Dry, MD, PhD

• Updates in Non-neoplastic Bone Pathology: Common Problems and Pitfalls and How to Avoid Them! – Scott Kilpatrick, MD

• Giant Cell Rich Tumors of Bone and Soft Tissue – Judith Bovée, MD, PhD

• Emerging Molecular-defined Bone and Soft Tissue Diagnoses: When do they matter? – Jessica L. Davis, MD

• Methylation Profiles in Bone and Soft Tissue Tumors. Does it Help Classify the Unclassifiable? – Josephine K. Dermawan, MD, PhD

• Replacing Molecular Testing with Next-Generation Immunohistochemistry: I Can Diagnose that Soft Tissue Tumor with a Single Antibody! – Jason Hornick, MD, PhD

• Neoplastic and Non-Neoplastic Lesions of the Synovium – G. Petur Nielsen, MD

• Unraveling Round Cell Sarcomas : A Contemporary Diagnostic Guide Beyond Ewing Sarcoma – Raul Perret, MD, MSc